NISN yields 294.12% · MRK yields 2.76%● Live data
📍 NISN pulled ahead of the other in Year 1
Combined, NISN + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NISN + MRK for your $10,000?
Nisun International Enterprise Development Group Co., Ltd, an investment holding company, provides technology-driven integrated supply chain solutions for enterprises and financial institutions in the People's Republic of China and internationally. It offers professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions. The company also provides a range of technology-driven customized financing solutions to small- and mid-sized enterprises (SMEs) to enhance SMEs' access to capital through its closed-loop ecosystem built on fintech platforms; and direct banking solutions to small- and medium-sized commercial banks and other financial institutions in their distribution and management of direct banking and other financial products. Nisun International Enterprise Development Group Co., Ltd has a strategic collaboration with Henan Wanbang International Agricultural Products Logistics Co., Ltd. for cooperation on businesses related to the agricultural field. The company was formerly known as Hebron Technology Co., Ltd. and changed its name to Nisun International Enterprise Development Group Co., Ltd in September 2020. Nisun International Enterprise Development Group Co., Ltd was founded in 2005 and is headquartered in Shanghai, the People's Republic of China.
Full NISN Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.